Cell cycle abnormalities in squamous cell carcinoma of the cervix

CME Journal of Gynecologic Oncology

Volumn 6, Issue 2, 2001, Pages 167-172

  Shin, B ^a   Dubeau, L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell cycle abnormalities; Cervical carcinoma; HPV

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA; PHOSPHOTRANSFERASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

CELL CYCLE; CELL DIVISION; DNA REPLICATION; ENZYME INACTIVATION; FEMALE; GENE MUTATION; HUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0034771403     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Regulation of CDK/cyclin complexes during the cell cycle
2. Cyclins and cell cycle checkpoints
3. Identification of multiple cyclin subunits of human P-TEFb
4. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II
5. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
6. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin Ddependent kinase CDK4
7. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of CDK4 activity
8. G1 phase progression: Cycling on cue
9. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
10. Human cyclin E, a nuclear protein essential for the Gl-to-S phase transition
11. Mitosis in transition
12. The retinoblastoma protein pathway in cell cycle control and cancer
13. Cancer cell cycles
14. Unrestricted cell cycling and cancer
15. The retinoblastoma protein and cell cycle control
16. pRB, p107 and the regulation of the E2F transcription factor
17. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein
18. The interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F
19. Mechanism of active transcriptional repression by the retinoblastoma protein
20. Differential regulation of E2F transactivation by cyclin/CDK2 complexes
21. Cell cycle checkpoints: Preventing an identity crisis
22. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
23. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members
24. Transcriptional repression by the Rb-related protein p107
25. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
26. A cyclin associated with the CDK-activating kinase MO15
27. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor
28. Association of Cdk-activating kinase subunits with transcription factor TFIIH
29. Cdk-activating kinase complex is a component of human transcription factor TFIIH
30. Identification of a cyclin-CDK2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors
31. WAF1, a potential mediator of p53 tumor suppression
32. P15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
33. A cell cycle regulator potentially involved in genesis of many tumor types
34. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
35. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
36. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb
37. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene
38. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with CDK4 and CDK2
39. Perspective: Defects in cell cycle control and cancer
40. Specific regulation of E2F family members by cyclin-dependent kinases
41. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A
42. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
43. The p53 tumor suppressor protein: Meeting review
44. The p53 pathway
45. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
46. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6
47. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines
48. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity
49. Ordering S phase and M phase in the cell cycle
50. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases
51. Activation of CDC 25 phosphatase and CDC 2 kinase involved in GL331-induced apoptosis
52. Molecular events in uterine cervical cancer
53. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy
54. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
55. Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors
56. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes
57. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia
58. Genetics of growth arrest and cell death: Key determinants of tissue homeostasis
59. The role of the E6-p53 interaction in the molecular pathogenesis of HPV
60. Prospective study of a family cancer syndrome
61. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation
62. Evidence for keratinocyte immortalization in high-grade squamous intraepithelial lesions of the cervix infected with high-risk human papillomaviruses
63. Telomeres, telomerase, and immortality
64. Telomerase activation in cervical cancer
65. Specific association of human telomerase activity with immortal cells and cancer
66. Telomerase activation by the E6 gene product of human papillomavirus type 16
67. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors
68. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16
69. Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein
70. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of CDK2
71. Inactivation of the CDK inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein